Sunday (23.10.2022)

07:30 – 09:00

Scientific Session Interactive Case Discussion

  • Case presentation: Greyzone Lymphoma

  • Case presentation: Anti-PD1 Failure

  • Case presentation: COVID19 immunity in lymphoma

  • Case presentation: Primary progressive HL

09:15 – 10:15

Scientific Session Emerging Cellular Therapies – a Role in HL?

  • Emerging indications for cellular therapy

  • Cellular Therapy in HL

  • New concepts in cellular therapy

10:30 – 12:00

Scientific Session Living beyond Lymphoma

  • Heart & Lung Toxicity a er HL Treatment

  • Informed decision making

  • WS Report: Living beyond Lymphoma

12:15 – 13:45

Satellite Symposium Satellite Symposium

14:00 – 15:30

Scientific Session Older and Frail Patients

  • Treatment Allocation in Older HL Patients

  • Managing an Older Lymphoma Patient

  • WS Report: Older Patients

16:00 – 17:30

Scientific Session Satellite Symposium

18:00 – 19:30

Scientific Session Immunotherapy

  • Immunotherapy approaches in 1ˢᵗ-line HL

  • How I currently treat HL with immunotherapy

  • Vision Corner

ISHL12 Preliminary Program at a Glance (PDF)

ISHL12 Preliminary Program at a Glance (PDF)